161 related articles for article (PubMed ID: 36551604)
1. MRI Radiomics for Predicting Survival in Patients with Locally Advanced Hypopharyngeal Cancer Treated with Concurrent Chemoradiotherapy.
Siow TY; Yeh CH; Lin G; Lin CY; Wang HM; Liao CT; Toh CH; Chan SC; Lin CP; Ng SH
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551604
[TBL] [Abstract][Full Text] [Related]
2. MRI-based radiomics value for predicting the survival of patients with locally advanced cervical squamous cell cancer treated with concurrent chemoradiotherapy.
Zhang X; Zhao J; Zhang Q; Wang S; Zhang J; An J; Xie L; Yu X; Zhao X
Cancer Imaging; 2022 Jul; 22(1):35. PubMed ID: 35842679
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of the radiomics-based model in progression-free survival of hypopharyngeal cancer treated with chemoradiation.
Mo X; Wu X; Dong D; Guo B; Liang C; Luo X; Zhang B; Zhang L; Dong Y; Lian Z; Liu J; Pei S; Huang W; Ouyang F; Tian J; Zhang S
Eur Radiol; 2020 Feb; 30(2):833-843. PubMed ID: 31673835
[TBL] [Abstract][Full Text] [Related]
4. Early risk-assessment of patients with nasopharyngeal carcinoma: the added prognostic value of MR-based radiomics.
Kim MJ; Choi Y; Sung YE; Lee YS; Kim YS; Ahn KJ; Kim MS
Transl Oncol; 2021 Oct; 14(10):101180. PubMed ID: 34274801
[TBL] [Abstract][Full Text] [Related]
5. MRI radiomics in overall survival prediction of local advanced cervical cancer patients tread by adjuvant chemotherapy following concurrent chemoradiotherapy or concurrent chemoradiotherapy alone.
Wei G; Jiang P; Tang Z; Qu A; Deng X; Guo F; Sun H; Zhang Y; Gu L; Zhang S; Mu W; Wang J; Tian J
Magn Reson Imaging; 2022 Sep; 91():81-90. PubMed ID: 35636572
[TBL] [Abstract][Full Text] [Related]
6. Outcome prediction of head and neck squamous cell carcinoma by MRI radiomic signatures.
Mes SW; van Velden FHP; Peltenburg B; Peeters CFW; Te Beest DE; van de Wiel MA; Mekke J; Mulder DC; Martens RM; Castelijns JA; Pameijer FA; de Bree R; Boellaard R; Leemans CR; Brakenhoff RH; de Graaf P
Eur Radiol; 2020 Nov; 30(11):6311-6321. PubMed ID: 32500196
[TBL] [Abstract][Full Text] [Related]
7. A multiple-time-scale comparative study for the added value of magnetic resonance imaging-based radiomics in predicting pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Peng W; Wan L; Wang S; Zou S; Zhao X; Zhang H
Front Oncol; 2023; 13():1234619. PubMed ID: 37664046
[TBL] [Abstract][Full Text] [Related]
8. Radiomics may increase the prognostic value for survival in glioblastoma patients when combined with conventional clinical and genetic prognostic models.
Choi Y; Nam Y; Jang J; Shin NY; Lee YS; Ahn KJ; Kim BS; Park JS; Jeon SS; Hong YG
Eur Radiol; 2021 Apr; 31(4):2084-2093. PubMed ID: 33006658
[TBL] [Abstract][Full Text] [Related]
9. Delta-volume radiomics of induction chemotherapy to predict outcome of subsequent chemoradiotherapy for locally advanced hypopharyngeal cancer.
Su CW; Lee JC; Chang YF; Su NW; Lee PH; Dai KY; Tai HC; Leu YS; Chen YJ
Tumori; 2022 Oct; 108(5):450-460. PubMed ID: 34423708
[TBL] [Abstract][Full Text] [Related]
10. MRI Radiomic Features: Association with Disease-Free Survival in Patients with Triple-Negative Breast Cancer.
Kim S; Kim MJ; Kim EK; Yoon JH; Park VY
Sci Rep; 2020 Feb; 10(1):3750. PubMed ID: 32111957
[TBL] [Abstract][Full Text] [Related]
11. Whole-Volume Tumor MRI Radiomics for Prognostic Modeling in Endometrial Cancer.
Fasmer KE; Hodneland E; Dybvik JA; Wagner-Larsen K; Trovik J; Salvesen Ø; Krakstad C; Haldorsen IHS
J Magn Reson Imaging; 2021 Mar; 53(3):928-937. PubMed ID: 33200420
[TBL] [Abstract][Full Text] [Related]
12. MRI-based random survival Forest model improves prediction of progression-free survival to induction chemotherapy plus concurrent Chemoradiotherapy in Locoregionally Advanced nasopharyngeal carcinoma.
Pei W; Wang C; Liao H; Chen X; Wei Y; Huang X; Liang X; Bao H; Su D; Jin G
BMC Cancer; 2022 Jul; 22(1):739. PubMed ID: 35794590
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of interim CT-based peritumoral and intratumoral radiomics in laryngeal and hypopharyngeal cancer patients undergoing definitive radiotherapy.
Lin CH; Yan JL; Yap WK; Kang CJ; Chang YC; Tsai TY; Chang KP; Liao CT; Hsu CL; Chou WC; Wang HM; Huang PW; Fan KH; Huang BS; Tung-Chieh Chang J; Tu SJ; Lin CY
Radiother Oncol; 2023 Dec; 189():109938. PubMed ID: 37806562
[TBL] [Abstract][Full Text] [Related]
14. MRI-based radiomics to predict neoadjuvant chemoradiotherapy outcomes in locally advanced rectal cancer: A multicenter study.
Xiang Y; Li S; Wang H; Song M; Hu K; Wang F; Wang Z; Niu Z; Liu J; Cai Y; Li Y; Zhu X; Geng J; Zhang Y; Teng H; Wang W
Clin Transl Radiat Oncol; 2023 Jan; 38():175-182. PubMed ID: 36471751
[TBL] [Abstract][Full Text] [Related]
15. MRI-based radiomics for pretreatment prediction of response to concurrent chemoradiotherapy in locally advanced cervical squamous cell cancer.
Zhang X; Zhang Q; Chen Y; Wang S; Zhang J; An J; Xie L; Yu X; Zhao X
Abdom Radiol (NY); 2023 Jan; 48(1):367-376. PubMed ID: 36222869
[TBL] [Abstract][Full Text] [Related]
16. Radiomics risk score may be a potential imaging biomarker for predicting survival in isocitrate dehydrogenase wild-type lower-grade gliomas.
Park CJ; Han K; Kim H; Ahn SS; Choi YS; Park YW; Chang JH; Kim SH; Jain R; Lee SK
Eur Radiol; 2020 Dec; 30(12):6464-6474. PubMed ID: 32740813
[TBL] [Abstract][Full Text] [Related]
17. MRI-based radiomics to compare the survival benefit of induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma: A multicenter study.
Shen H; Yin J; Niu R; Lian Y; Huang Y; Tu C; Liu D; Wang X; Lan X; Yuan X; Zhang J
Radiother Oncol; 2022 Jun; 171():107-113. PubMed ID: 35461950
[TBL] [Abstract][Full Text] [Related]
18. CT radiomics-based long-term survival prediction for locally advanced non-small cell lung cancer patients treated with concurrent chemoradiotherapy using features from tumor and tumor organismal environment.
Chen NB; Xiong M; Zhou R; Zhou Y; Qiu B; Luo YF; Zhou S; Chu C; Li QW; Wang B; Jiang HH; Guo JY; Peng KQ; Xie CM; Liu H
Radiat Oncol; 2022 Nov; 17(1):184. PubMed ID: 36384755
[TBL] [Abstract][Full Text] [Related]
19. Multi-Habitat Based Radiomics for the Prediction of Treatment Response to Concurrent Chemotherapy and Radiation Therapy in Locally Advanced Cervical Cancer.
Fang M; Kan Y; Dong D; Yu T; Zhao N; Jiang W; Zhong L; Hu C; Luo Y; Tian J
Front Oncol; 2020; 10():563. PubMed ID: 32432035
[No Abstract] [Full Text] [Related]
20. Radiomic MRI Phenotyping of Glioblastoma: Improving Survival Prediction.
Bae S; Choi YS; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK
Radiology; 2018 Dec; 289(3):797-806. PubMed ID: 30277442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
